Simultaneously, Novonesis is making a minor investment into TurtleTree. 321Catalyst Ventures, the CVC-arm of Mitsui Chemicals, Inc. (HQ: Tokyo) joins the investment.
Tetra Pak Bioreactor RF enables stable, scalable fermentation with reduced risk, faster start-up and up to 12% lower operational costs, from pilot to full production.
The new plant features enhanced mixing precision, with dosage control, cross-contamination mitigation and agile traceability capabilities.
Verax™ was first introduced for broilers, where it has been credited with enhancing decision-making and reducing reliance on antibiotics.
These capital investments will focus on operations and logistic capabilities as well as updating its Innovation center for world class product development and customer collaboration.